Skip to main content
Erschienen in: BMC Pediatrics 1/2024

Open Access 01.12.2024 | Case Report

Large skin defect in Type V aplasia cutis congenita treated with conservative treatment: a case report

verfasst von: Yan song, Ru yang, Zeyao shi, Jing yan, Shulin hou, Xiaowen li, Xiufang zhao

Erschienen in: BMC Pediatrics | Ausgabe 1/2024

Abstract

Aplasia cutis congenita (ACC) is a congenital disorder that can be classified into nine types, with Type I ACC being the most common. Type V ACC associated with fetus papyraceus is a rare subtype of ACC. We report the case of a Type V ACC in a male newborn with extensive abdominal skin defects. The patient received conservative treatment using hydrogel foam and silicone foam dressings. Approximately five weeks later, the patient was discharged when more than 60% of the skin had completed epithelialization. After discharge from West China Second University Hospital, Chengdu , the patient continued to be followed up regularly at the Burns and Plastic Surgery Clinic at local hospital in Gansu. We followed up the child by telephone. After 4 months of follow-up, scar tissue formation was observed in the trunk area. The infant is 2 years and 5 months old now, physical examination did not reveal any organ problems.
Hinweise
Yan song and Ru yang contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ACC
Aplasia cutis congenita
NICU
Neonatal intensive care unit
EB
Epidermolysis bullosa

Introduction

Aplasia cutis congenita (ACC) is a rare, congenital disorder characterized by localized or widespread absence of skin at birth with various etiologies and heterogeneous clinical presentation [1]. The precise incidence of ACC is unknown but thought to be around 0.5/10 000 in Europe [2]. However, the actual incidence may be higher, because cases of mild ACC are probably underreported [3]. Skin lesions can occur anywhere on the body, but 80% and even more cases of ACC have involved the scalp, others (15%) could be found on the trunk and limbs [2, 4]. ACC may be an isolated skin malformation involving one or more skin districts, and it may also merge with multiple other organ malformations [5]. The defect may be superficial, depth varies from the absence of epidermis and upper dermis only to subcutaneous tissue. In some severe cases, it may extend to deeper tissues, such as the muscle or bone (periosteum, skull, and dura).
The most widely used classification of ACC was proposed by Frieden in 1986. Frieden grouped ACC into nine subtypes based on its associated abnormalities, inheritance pattern, and body area affected [6]. Type I ACC is the most common type, and most of them are without underlying syndromes, malformations, or other abnormalities. Type V is rare, associated with fetus papyraceus or placental infarction, and characterized by a symmetrical and H-shaped distribution over the trunk and extremities [7]. Here, we successfully treated a patient with extensive abdominal skin defects with conservative treatment.

Case history

An infant with a birth weight of 2350g, was delivered through cesarean section at 37 weeks of gestation at a local hospital in Gansu (438 km far from West China Second University Hospital, Chengdu). The mother was a 35-year-old healthy primigravid woman who conceived a monocorionic diamniotic twin pregnancy naturally. The mother experienced fetal demise of one fetus at 13-14 weeks of gestation. During the pregnancy, the mother had no history of taking medicine and did not experience remarkable complications during the rest of the pregnancy. The surviving one was admitted to our hospital less than 24 hours after birth due to significant skin defects on the trunk. There were symmetrical skin defects in the abdomen and bilateral trunk, measuring approximately 17 × 4 cm. The lesions appeared to be a complete absence of epidermis, dermis, and subcutaneous fat. The defects exhibited clear boundaries and were covered only by a thin gelatinous translucent membrane, revealing visible ribs and blood vessels (Fig. 1). No skin defects were observed in other areas, and the remaining physical examination and complementary exams such as ultrasound of the chest and abdomen showed no abnormality. These indicated that the patient has no combination of deformities or defects other than abdominal skin defects.
The patient was diagnosed with "Type V aplasia cutis congenita" based on the clinical manifestations and the Frieden classification. Due to the large defect skin and the presence of vital organs in the abdominal area such as the liver, and intestines. The primary focus of the patient was the local wound management. The main principles of wound treatment included maintaining adequate moisture in the wound, promoting epithelial tissue growth, and preventing infection. The patient received treatment with lipid hydrogel foam dressing (Urgotul®), silicone foam dressing (ALLEVYN GENTLE BORDER), and growth factors (Fig. 2). Additionally, prophylactic antibiotics were administered intravenously using Cefoperazone sodium tazobactam sodium. Following approximately five weeks of the treatment, the patient was discharged from the neonatal intensive care unit (NICU) when more than 60% of the lesion showed epithelialization. Throughout the hospitalization period, the patient did not experience systemic or local infections, nor did they develop severe complications such as electrolyte imbalance or bleeding. After discharge from the West China Second University Hospital, Chengdu, the patient continued to be followed up regularly at the Burns and Plastic Surgery Clinic for dressing changes and observation of wound healing at local hospital in Gansu. We followed up the child by telephone. After 4 months of follow-up, scar tissue formation was observed in the trunk area (Fig. 3). The infant is 2 years and 5 months old now, physical examination did not reveal any organ problems.

Discussion and conclusions

Type V ACC is rare, associated with fetus papyraceus or placental infarction, and characterized by a symmetrical and H-shaped distribution over the trunk and extremities. The pathogenesis of ACC is unknown, multiple factors might be contributing to the development of ACC. ACC is associated with chromosomal abnormalities, amniotic irregularities, vascular disorders, fetus papyraceus, and pregnancy infection (herpes simplex virus and varicella virus). Otherwise, the use of some teratogenic drugs during the mother’s pregnancy might increase the risk of ACC, such as misoprostol, benzodiazepines, valproic acid, cocaine, and methimazole [8]. Besides, several genes are causing Adams-Oliver Syndrome (diagnosed in the presence of ACC of the scalp and terminal transverse limb defects), such as DLL4, NOTCH1, DOCK6 and EOGT [9, 10]. Several heterozygous mutations in COL7A1 may result in Bart’s syndrome, which is characterized by ACC and epidermolysis bullosa (EB) [11, 12]. Genetic mutations in the COL7A1 gene are also associated with dystrophic EB [13]. Moreover, ACC can be associated with physical defects or syndromes. In the case of children diagnosed with trisomy 18, membrane ACC has been observed on the skull [14, 15].
Several theories have been proposed to explain the pathomechanism of Type V ACC. Although the exact cause is not yet known, most recent evidence tended to support transient hypovolemia as the primary cause [16]. Intrauterine death of one twin results in rapid blood shunting from the surviving fetus to the dying one [17]. Especially in monochorionic pregnancies, this acute transfusion between twins could induce acute hypovolemia in the living twin, resulting in ischemia of the skin and other organs [18, 19]. Monochorionic twin pregnancies have greater morbidity risk than dichorionic twin pregnancies, possibly because placental vascular anastomoses produce anomalous fetal-fetal transfusion [20]. Arteriovenous vascular anastomoses are found in 90-95% of monochorionic placentas [21]. Otherwise, studies suggested that in the presence of late first to early second-trimester fetal death in an initial twin gestation pregnancy, small abdominal circumference, detectable acetylcholinesterase, high amniotic and maternal alpha-fetoprotein could suggest the diagnosis of ACC with fetus papyraceous [22].
Most ACCs were generally treated with conservative measures and took approximately 6 weeks to fully epithelialize. Conservative treatment focuses on keeping the wound sufficiently moist, promoting epithelial tissue growth, and preventing infection [23]. Conservative treatment includes various dressings, topical antimicrobials, and systemic antibiotics [24]. Dressings used include ionic silver dressing, moist exposed burn ointment, hydrogels, adhesive or nonadherent dressings, basic fibroblast growth factor, and recombinant human epidermal growth factor [2528]. The benefit of conservative treatment of ACC is the avoidance of the risks associated with surgery. However, when there is a large area of skin defect in important areas, such as the scalp, surgical approaches can be used to prevent morbidity and mortality from central nervous system related complications such as meningitis, sagittal sinus bleeding, and cerebral hernia. Surgical options include local or free flaps, skin grafting, acellular dermal matrix, allogenic dermis, and cultured epithelial allografts [2935]. A child with a large total body surface area of ACC (37%) involving the entire scalp, chest, and trunk was successfully treated using acellular dermal matrix and cultured epithelial allografts [32]. Other surgical treatments of ACC on the scalp or skull include delayed cranioplasty, early composite cranioplasty, and tissue expanders [36].
The patient received conservative treatment with lipid hydrogel foam dressing (Urgotul®), silicone foam dressing (ALLEVYN GENTLE BORDER), and growth factors. Following approximately five weeks of the treatment, the patient was discharged from the NICU when more than 60% of the lesion showed epithelialization. Most children with Type V ACC can be treated conservatively with satisfactory results.

Acknowledgements

We thank all the participants in this study and all clinicians who were involved in the collection.

Declarations

Not applicable.
The parents of this patient consented to the publication of the case and any accompanying images with written informed consent.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Humphrey SR, et al. A practical approach to the evaluation and treatment of an infant with aplasia cutis congenita. J Perinatol. 2018;38(2):110–7.CrossRefPubMed Humphrey SR, et al. A practical approach to the evaluation and treatment of an infant with aplasia cutis congenita. J Perinatol. 2018;38(2):110–7.CrossRefPubMed
2.
Zurück zum Zitat Coi A, et al. Epidemiology of aplasia cutis congenita: a population-based study in Europe. J Eur Acad Dermatol Venereol. 2023;37(3):581–9.CrossRefPubMed Coi A, et al. Epidemiology of aplasia cutis congenita: a population-based study in Europe. J Eur Acad Dermatol Venereol. 2023;37(3):581–9.CrossRefPubMed
3.
Zurück zum Zitat Hioki T, et al. Infant bald patch: ultrasonographic diagnosis of aplasia cutis congenita. J Eur Acad Dermatol Venereol. 2017;31(6):e276–7.CrossRefPubMed Hioki T, et al. Infant bald patch: ultrasonographic diagnosis of aplasia cutis congenita. J Eur Acad Dermatol Venereol. 2017;31(6):e276–7.CrossRefPubMed
4.
Zurück zum Zitat Sathishkumar D, Ogboli M, Moss C. Classification of aplasia cutis congenita: a 25-year review of cases presenting to a tertiary paediatric dermatology department. Clin Exp Dermatol. 2020;45(8):994–1002.CrossRefPubMed Sathishkumar D, Ogboli M, Moss C. Classification of aplasia cutis congenita: a 25-year review of cases presenting to a tertiary paediatric dermatology department. Clin Exp Dermatol. 2020;45(8):994–1002.CrossRefPubMed
5.
Zurück zum Zitat Mesrati H, et al. Aplasia cutis congenita: report of 22 cases. Int J Dermatol. 2015;54(12):1370–5.CrossRefPubMed Mesrati H, et al. Aplasia cutis congenita: report of 22 cases. Int J Dermatol. 2015;54(12):1370–5.CrossRefPubMed
6.
Zurück zum Zitat Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol. 1986;14(4):646–60.CrossRefPubMed Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol. 1986;14(4):646–60.CrossRefPubMed
7.
Zurück zum Zitat Silva Díaz E, et al. Type V aplasia cutis congenita in a preterm newborn successfully resolved. Dermatol Ther. 2020;33(6):e13888.CrossRefPubMed Silva Díaz E, et al. Type V aplasia cutis congenita in a preterm newborn successfully resolved. Dermatol Ther. 2020;33(6):e13888.CrossRefPubMed
8.
Zurück zum Zitat Karg E, et al. Aplasia cutis congenita after methimazole exposure in utero. Pediatr Dermatol. 2004;21(4):491–4.CrossRefPubMed Karg E, et al. Aplasia cutis congenita after methimazole exposure in utero. Pediatr Dermatol. 2004;21(4):491–4.CrossRefPubMed
9.
Zurück zum Zitat Zepeda-Romero LC, et al. Intrafamilial phenotypic variability in autosomal recessive DOCK6-related Adams-Oliver syndrome. Eur J Med Genet. 2022;65(12):104653.CrossRefPubMed Zepeda-Romero LC, et al. Intrafamilial phenotypic variability in autosomal recessive DOCK6-related Adams-Oliver syndrome. Eur J Med Genet. 2022;65(12):104653.CrossRefPubMed
10.
Zurück zum Zitat Rojnueangnit K, et al. A novel DLL4 mutation in Adams-Oliver syndrome with absence of the right pulmonary artery in newborn. Am J Med Genet A. 2022;188(2):658–64.CrossRefPubMed Rojnueangnit K, et al. A novel DLL4 mutation in Adams-Oliver syndrome with absence of the right pulmonary artery in newborn. Am J Med Genet A. 2022;188(2):658–64.CrossRefPubMed
11.
Zurück zum Zitat Han YM, et al. Bart’s syndrome with novel frameshift mutations in the COL7A1 Gene. Fetal Pediatr Pathol. 2019;38(1):72–9.CrossRefPubMed Han YM, et al. Bart’s syndrome with novel frameshift mutations in the COL7A1 Gene. Fetal Pediatr Pathol. 2019;38(1):72–9.CrossRefPubMed
12.
Zurück zum Zitat Chen Z, et al. Bart’s syndrome in a family affected three consecutive generations with mutation c.6007G>A in COL7A1. J Dermatol. 2018;45(8):1000–2.CrossRefPubMed Chen Z, et al. Bart’s syndrome in a family affected three consecutive generations with mutation c.6007G>A in COL7A1. J Dermatol. 2018;45(8):1000–2.CrossRefPubMed
13.
Zurück zum Zitat Chiaverini C, et al. Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational study. Br J Dermatol. 2014;170(4):901–6.CrossRefPubMed Chiaverini C, et al. Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational study. Br J Dermatol. 2014;170(4):901–6.CrossRefPubMed
15.
Zurück zum Zitat raMeSh PotPalle D. Edward syndrome with aplasia cutis congenita: a rare case report. Indian J Neonatal Med Res. 2015;4(1):7–9. raMeSh PotPalle D. Edward syndrome with aplasia cutis congenita: a rare case report. Indian J Neonatal Med Res. 2015;4(1):7–9.
16.
Zurück zum Zitat Pieretti ML, et al. Aplasia cutis congenita associated with fetus papyraceus. Pediatric Dermatol. 2015;32(6):858–61.CrossRef Pieretti ML, et al. Aplasia cutis congenita associated with fetus papyraceus. Pediatric Dermatol. 2015;32(6):858–61.CrossRef
17.
Zurück zum Zitat Lewi L, et al. Monochorionic diamniotic twins: complications and management options. Curr Opin Obstet Gynecol. 2003;15(2):177–94.CrossRefPubMed Lewi L, et al. Monochorionic diamniotic twins: complications and management options. Curr Opin Obstet Gynecol. 2003;15(2):177–94.CrossRefPubMed
18.
Zurück zum Zitat Klein RQ, et al. Symmetric aplasia cutis congenita associated with fetus papyraceus: report of two cases. Pediatr Dermatol. 2011;28(4):467–9.CrossRefPubMed Klein RQ, et al. Symmetric aplasia cutis congenita associated with fetus papyraceus: report of two cases. Pediatr Dermatol. 2011;28(4):467–9.CrossRefPubMed
19.
Zurück zum Zitat Louise L, et al. Fetus papyraceus: congenital pulmonary anomalies associated with congenital aplasia cutis on the surviving twin. Pediatr Dermatol. 2013;30(6):e143–5.CrossRefPubMed Louise L, et al. Fetus papyraceus: congenital pulmonary anomalies associated with congenital aplasia cutis on the surviving twin. Pediatr Dermatol. 2013;30(6):e143–5.CrossRefPubMed
20.
Zurück zum Zitat Lewi L. Monochorionic diamniotic twin pregnancies. Am J Obstet Gynecol MFM. 2022;4(2S):100501.CrossRefPubMed Lewi L. Monochorionic diamniotic twin pregnancies. Am J Obstet Gynecol MFM. 2022;4(2S):100501.CrossRefPubMed
22.
Zurück zum Zitat Mazza JM, et al. Aplasia cutis congenita in a setting of fetus papyraceus associated with small fetal abdominal circumference and high alpha-fetoprotein and amniotic acetylcholinesterase. Pediatr Dermatol. 2015;32(1):138–40.CrossRefPubMed Mazza JM, et al. Aplasia cutis congenita in a setting of fetus papyraceus associated with small fetal abdominal circumference and high alpha-fetoprotein and amniotic acetylcholinesterase. Pediatr Dermatol. 2015;32(1):138–40.CrossRefPubMed
23.
Zurück zum Zitat Başterzi Y, et al. Aplasia cutis congenita of the scalp and calvarium: conservative wound management with novel wound dressing materials. J Craniofac Surg. 2007;18(2):427–9.CrossRefPubMed Başterzi Y, et al. Aplasia cutis congenita of the scalp and calvarium: conservative wound management with novel wound dressing materials. J Craniofac Surg. 2007;18(2):427–9.CrossRefPubMed
24.
Zurück zum Zitat Bernbeck B, et al. Aplasia cutis congenita of the scalp: how much therapy is necessary in large defects? Acta Paediatr. 2005;94(6):758–60.CrossRefPubMed Bernbeck B, et al. Aplasia cutis congenita of the scalp: how much therapy is necessary in large defects? Acta Paediatr. 2005;94(6):758–60.CrossRefPubMed
25.
Zurück zum Zitat Lei G-F, et al. Treating aplasia cutis congenita in a newborn with the combination of ionic silver dressing and moist exposed burn ointment: a case report. World J Clin Cases. 2019;7(17):2611–6.CrossRefPubMedPubMedCentral Lei G-F, et al. Treating aplasia cutis congenita in a newborn with the combination of ionic silver dressing and moist exposed burn ointment: a case report. World J Clin Cases. 2019;7(17):2611–6.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Lahiri A, Nishikawa H. A nonadherent dressing for aplasia cutis congenita. J Plast Reconstr Aesthet Surg. 2006;59(7):781–2.CrossRefPubMed Lahiri A, Nishikawa H. A nonadherent dressing for aplasia cutis congenita. J Plast Reconstr Aesthet Surg. 2006;59(7):781–2.CrossRefPubMed
27.
Zurück zum Zitat Orgun D, et al. Conservative treatment of large aplasia cutis congenita of the scalp with bone defect with basic fibroblast growth factor application. J Craniofac Surg. 2017;28(2):e154–8.CrossRefPubMed Orgun D, et al. Conservative treatment of large aplasia cutis congenita of the scalp with bone defect with basic fibroblast growth factor application. J Craniofac Surg. 2017;28(2):e154–8.CrossRefPubMed
28.
Zurück zum Zitat Yang X-F, Shi S-W, Chen K. Case report: recombinant human epidermal growth factor gel plus kangfuxin solution in the treatment of aplasia cutis congenita in a case with Adams-Oliver syndrome. Front Surg. 2022;9:1072021.CrossRefPubMed Yang X-F, Shi S-W, Chen K. Case report: recombinant human epidermal growth factor gel plus kangfuxin solution in the treatment of aplasia cutis congenita in a case with Adams-Oliver syndrome. Front Surg. 2022;9:1072021.CrossRefPubMed
29.
Zurück zum Zitat Park ES, et al. Clinical application of acellular dermal matrix in the treatment of aplasia cutis congenita on scalp. J Craniofac Surg. 2017;28(8):e788–9.CrossRefPubMed Park ES, et al. Clinical application of acellular dermal matrix in the treatment of aplasia cutis congenita on scalp. J Craniofac Surg. 2017;28(8):e788–9.CrossRefPubMed
30.
Zurück zum Zitat Simman R, Priebe CJ, Simon M. Reconstruction of aplasia cutis congenita of the trunk in a newborn infant using acellular allogenic dermal graft and cultured epithelial autografts. Ann Plast Surg. 2000;44(4):451–4.CrossRefPubMed Simman R, Priebe CJ, Simon M. Reconstruction of aplasia cutis congenita of the trunk in a newborn infant using acellular allogenic dermal graft and cultured epithelial autografts. Ann Plast Surg. 2000;44(4):451–4.CrossRefPubMed
31.
Zurück zum Zitat Trah J, et al. Integra®-dermal regeneration template and split-thickness skin grafting: a therapy approach to correct aplasia cutis congenita and epidermolysis bullosa in carmi syndrome. Dermatol Ther. 2018;8(2):313–21.CrossRef Trah J, et al. Integra®-dermal regeneration template and split-thickness skin grafting: a therapy approach to correct aplasia cutis congenita and epidermolysis bullosa in carmi syndrome. Dermatol Ther. 2018;8(2):313–21.CrossRef
32.
Zurück zum Zitat Hui CLY, et al. A rare case of extensive aplasia cutis congenita: our surgical approach. J Plast Reconstr Aesthet Surg. 2023;80:193–9.CrossRefPubMed Hui CLY, et al. A rare case of extensive aplasia cutis congenita: our surgical approach. J Plast Reconstr Aesthet Surg. 2023;80:193–9.CrossRefPubMed
33.
Zurück zum Zitat Mericli AF, et al. Calvarial regeneration with use of acellular dermal matrix in aplasia cutis congenita. J Craniofac Surg. 2015;26(6):1960–2.CrossRefPubMed Mericli AF, et al. Calvarial regeneration with use of acellular dermal matrix in aplasia cutis congenita. J Craniofac Surg. 2015;26(6):1960–2.CrossRefPubMed
34.
Zurück zum Zitat Scotti A, et al. A case of large aplasia cutis congenita with underlying skull defect: effective surgical treatment with integra® dermal regeneration template. Pediatr Neurosurg. 2021;56(3):268–73.CrossRefPubMed Scotti A, et al. A case of large aplasia cutis congenita with underlying skull defect: effective surgical treatment with integra® dermal regeneration template. Pediatr Neurosurg. 2021;56(3):268–73.CrossRefPubMed
35.
Zurück zum Zitat Bharti G, et al. Aplasia cutis congenita: clinical management of a rare congenital anomaly. J Craniofac Surg. 2011;22(1):159–65.CrossRefPubMed Bharti G, et al. Aplasia cutis congenita: clinical management of a rare congenital anomaly. J Craniofac Surg. 2011;22(1):159–65.CrossRefPubMed
36.
Zurück zum Zitat Hadad I, Meara JG, Rogers-Vizena CR. A novel local autologous bone graft donor site after scalp tissue expansion in aplasia cutis congenita. J Craniofac Surg. 2016;27(4):904–7.CrossRefPubMed Hadad I, Meara JG, Rogers-Vizena CR. A novel local autologous bone graft donor site after scalp tissue expansion in aplasia cutis congenita. J Craniofac Surg. 2016;27(4):904–7.CrossRefPubMed
Metadaten
Titel
Large skin defect in Type V aplasia cutis congenita treated with conservative treatment: a case report
verfasst von
Yan song
Ru yang
Zeyao shi
Jing yan
Shulin hou
Xiaowen li
Xiufang zhao
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Pediatrics / Ausgabe 1/2024
Elektronische ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-024-04777-0

Weitere Artikel der Ausgabe 1/2024

BMC Pediatrics 1/2024 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.